The activity of a potent neutralizing human antibody against primary isolates in vivo

The activity of a potent neutralizing human antibody against primary isolates in vivo

Bibliographic Details
Main Authors:	Burton, DR, Parren, P, Poignard, P, Mosier, D, Gauduin, M, Koup, R, Sattentau, Q
Format:	Conference item
Published:	1998

Similar Items

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.
by: Parren, P, et al.
Published: (1997)

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".
by: Parren, P, et al.
Published: (1997)

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design (vol 57, pg 105, 1997)
by: Parren, P, et al.
Published: (1997)

Antibody neutralization of HIV-1.
by: Poignard, P, et al.
Published: (1996)

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
by: Parren, P, et al.
Published: (1999)

HIV-1 antibody--debris or virion?
by: Parren, P, et al.
Published: (1997)

HIV-1 antibody - Debris or virion? (vol 3, pg 366, 1997)
by: Parren, P, et al.
Published: (1997)

Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity.
by: Parren, P, et al.
Published: (1998)

Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.
by: Poignard, P, et al.
Published: (1996)

Antibody neutralization of HIV-1 and the potential for vaccine design.
by: Sattentau, Q, et al.
Published: (1999)

Mechanisms of virus neutralization by antibody.
by: Klasse, P, et al.
Published: (2001)

Neutralization of HIV-1 by antibody.
by: Sattentau, Q
Published: (1996)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
by: Julien J, et al.
Published: (2012-09-01)

HIV-1-CD4-coreceptor interactions in virus binding and neutralization
by: Sattentau, Q, et al.
Published: (1998)

Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization.
by: Ugolini, S, et al.
Published: (1997)

Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.
by: Moore, J, et al.
Published: (1995)

Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors
by: Pengfei Fan, et al.
Published: (2020-01-01)

Occupancy and mechanism in antibody-mediated neutralization of animal viruses.
by: Klasse, P, et al.
Published: (2002)

Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes
by: Qian Wu, et al.
Published: (2023-12-01)

Neutralization mechanisms of two highly potent antibodies against human enterovirus 71
by: Zhu, L, et al.
Published: (2018)

Neutralization mechanisms of two highly potent antibodies against human enterovirus 71
by: Zhu, L, et al.
Published: (2018)

A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.
by: Laura M Walker, et al.
Published: (2010-08-01)

Neutralization mechanism of a highly potent antibody against Zika virus
by: Shuijun Zhang, et al.
Published: (2016-11-01)

The evolution and determinants of neutralization of potent head-binding antibodies against Ebola virus
by: Xiaoying Yu, et al.
Published: (2023-11-01)

Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71
by: Ling Zhu, et al.
Published: (2018-09-01)

Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodies.
by: Schiffner, T, et al.
Published: (2013)

Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies
by: Krumm, S, et al.
Published: (2016)

Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus
by: Michael P. Doyle, et al.
Published: (2022-06-01)

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination
by: Xiaoyu Zhao, et al.
Published: (2024-02-01)

A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7
by: Rong Wang, et al.
Published: (2019-12-01)

Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
by: Cara W. Chao, et al.
Published: (2024-12-01)

Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
by: Ahmed M. Khalil, et al.
Published: (2023-07-01)

Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains
by: Li Chen, et al.
Published: (2024-04-01)

Correlates of antibody-mediated protection against HIV infection.
by: Sattentau, Q
Published: (2008)

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
by: Barouch, Dan H., et al.
Published: (2014)

Anti-idiotype isolation of a broad and potent influenza A virus-neutralizing human antibody
by: Adam S. Olia, et al.
Published: (2024-05-01)

A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
by: Meihui Xu, et al.
Published: (2017-01-01)

Nanoparticle-based multivalent human antibodies offer potent and broad neutralization against Omicron sublineages
by: Yizhen Wang, et al.
Published: (2023-08-01)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
by: Sisi Shan, et al.
Published: (2021-12-01)

Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus
by: Jiansheng Lu, et al.
Published: (2018-06-01)